{
    "id": 2602,
    "name": "chondroma",
    "source": "DOID",
    "definition": "A cell type benign neoplasm that is a cartilaginous tumor encapsulated with a lobular growing pattern. [url:http\\://en.wikipedia.org/wiki/Chondroma]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:2602",
    "evidence": [
        {
            "id": 12668,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, GI-6301 demonstrated safety and preliminary efficacy, induced brachyury-specific T-cell immune responses in 54% (14/31) of patients with solid tumors, resulted in disease control in 2 chordoma patients and prolonged stable disease in a patient with colorectal carcinoma (PMID: 26130065).",
            "molecularProfile": {
                "id": 28829,
                "profileName": "TBXT positive"
            },
            "therapy": {
                "id": 6570,
                "therapyName": "GI-6301",
                "synonyms": null
            },
            "indication": {
                "id": 2602,
                "name": "chondroma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 10573,
                    "pubMedId": 26130065,
                    "title": "Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26130065"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02834013",
            "title": "Nivolumab and Ipilimumab in Treating Patients With Rare Tumors",
            "phase": "Phase 0",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 1627,
                    "therapyName": "Ipilimumab + Nivolumab",
                    "synonyms": null
                }
            ]
        }
    ]
}